My current research focus is on the evaluation of glycine-based therapeutics in models of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly referred to as NAFLD). I utilize multi-omics analyses to characterize the mechanism of action of glycine-based therapeutics in rodent models of MASLD as well as elucidate new potential MASLD therapeutic targets.